Can we consider fludarabine full dose i.v. busulfan a reduced intensity conditioning regimen?

被引：0
|
作者：
Chunduri, S [1 ]
Jessop, E [1 ]
Dobogai, L [1 ]
Peace, D [1 ]
Saunthararajah, Y [1 ]
Chen, YH [1 ]
Mahmud, N [1 ]
Maynard, V [1 ]
Hoffman, R [1 ]
Rondelli, D [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.073
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
73
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [21] Reduced-Intensity Conditioning with Fludarabine and Busulfan: Age Has No Negative Impact On Survival
    Schneidawind, Dominik
    Federmann, Birgit
    Helwig, Andrea
    Vogel, Wichard
    Faul, Christoph
    Kanz, Lothar
    Bethge, Wolfgang A.
    BLOOD, 2012, 120 (21)
  • [22] Reduced-intensity conditioning with busulfan, fludarabine and alemtuzumab in children and adolescents: a pilot study
    Styczynski, J.
    Tallamy, B.
    Fearon, N.
    De Ven, C. Van
    Harrison, L.
    Morris, E.
    Satwani, P.
    Bhatia, M.
    George, D.
    Bradley, B.
    Garvin, J.
    Schwartz, J.
    Baxter-Lowe, L.
    Cairo, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S294 - S294
  • [23] BUSULFAN-BASED REDUCED INTENSITY CONDITIONING REGIMEN (RIC) FOR LYMPHOID MALIGNANCIES
    Sekhar, J.
    Stockerl-Goldstein, K.
    Cashen, A.
    Zhang, Q.
    Witowski, S.
    Abboud, C.
    Uy, G.
    Westervelt, P.
    Dipersio, J.
    Vij, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S283 - S283
  • [24] ROLE OF THIOTEPA DOSE IN THE CONDITIONING REGIMEN THIOTEPA-BUSULFAN-FLUDARABINE (TBF) FOR HAPLOIDENTICAL TRANSPLANTS
    Cigana, C.
    Patriarca, F.
    Lazzarotto, D.
    Geromin, A.
    Sperotto, A.
    Battista, M. L.
    Cerno, M.
    Medeot, M.
    Perali, G.
    Ventura, G.
    De Marchi, R.
    Fanin, R.
    HAEMATOLOGICA, 2016, 101 : S115 - S116
  • [25] Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases
    Nishimura, Akira
    Aoki, Yuki
    Ishiwata, Yasuyoshi
    Ichimura, Takuya
    Ueyama, Junichi
    Kawahara, Yuta
    Tomoda, Takahiro
    Inoue, Maiko
    Matsumoto, Kazuaki
    Inoue, Kento
    Hiroki, Haruka
    Ono, Shintaro
    Yamashita, Motoi
    Okano, Tsubasa
    Tanaka-Kubota, Mari
    Ashiarai, Miho
    Miyamoto, Satoshi
    Miyawaki, Reiji
    Yamagishi, Chika
    Tezuka, Mari
    Okawa, Teppei
    Hoshino, Akihiro
    Endo, Akifumi
    Yasuhara, Masato
    Kamiya, Takahiro
    Mitsuiki, Noriko
    Ono, Toshiaki
    Isoda, Takeshi
    Yanagimachi, Masakatsu
    Tomizawa, Daisuke
    Nagasawa, Masayuki
    Mizutani, Shuki
    Kajiwara, Michiko
    Takagi, Masatoshi
    Kanegane, Hirokazu
    Imai, Kohsuke
    Morio, Tomohiro
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (05) : 944 - 957
  • [26] Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis
    Jain, Tania
    Alandab, Fares
    Firwana, Belal
    Sonbol, Mohamad Bassam
    Almader-Douglas, Diana
    Palmer, Jeanne
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 728 - 733
  • [27] Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
    Epperla, Narendranath
    Ahn, Kwang Woo
    Armand, Philippe
    Jaglowski, Samantha
    Ahmed, Sairah
    Kenkre, Vaishalee P.
    Savani, Bipin
    Jagasia, Madan
    Shah, Nirav N.
    Fenske, Timothy S.
    Sureda, Anna
    Smith, Sonali M.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (01) : 78 - 85
  • [28] Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases
    Akira Nishimura
    Yuki Aoki
    Yasuyoshi Ishiwata
    Takuya Ichimura
    Junichi Ueyama
    Yuta Kawahara
    Takahiro Tomoda
    Maiko Inoue
    Kazuaki Matsumoto
    Kento Inoue
    Haruka Hiroki
    Shintaro Ono
    Motoi Yamashita
    Tsubasa Okano
    Mari Tanaka-Kubota
    Miho Ashiarai
    Satoshi Miyamoto
    Reiji Miyawaki
    Chika Yamagishi
    Mari Tezuka
    Teppei Okawa
    Akihiro Hoshino
    Akifumi Endo
    Masato Yasuhara
    Takahiro Kamiya
    Noriko Mitsuiki
    Toshiaki Ono
    Takeshi Isoda
    Masakatsu Yanagimachi
    Daisuke Tomizawa
    Masayuki Nagasawa
    Shuki Mizutani
    Michiko Kajiwara
    Masatoshi Takagi
    Hirokazu Kanegane
    Kohsuke Imai
    Tomohiro Morio
    Journal of Clinical Immunology, 2021, 41 : 944 - 957
  • [29] Comparison of Fixed Dose, Reduced-Intensity Conditioning with Busulfan and Fludarabine to Reduced PK-Guided Busulfan AUC Conditioning in Patients Undergoing Hematopoietic Stem Cell Transplant for AML/MDS
    Rasor, Brendan
    Dickerson, Tyler
    Zhao, Qiuhong
    Brammer, Jonathan E.
    Larkin, Karilyn
    Jaglowski, Samantha
    Mims, Alice S.
    Penza, Sam
    Vasu, Sumithira
    Wall, Sarah A.
    William, Basem M.
    Saad, Ayman
    Roddy, Julianna
    Choe, Hannah K.
    Puto, Marcin
    BLOOD, 2019, 134
  • [30] Comparison of Fixed Dose, Reduced-Intensity Conditioning with Busulfan and Fludarabine to Reduced PK-Guided Busulfan AUC Conditioning in Patients Undergoing Hematopoietic Stem Cell Transplant for AML/MDS
    Rasor, Brendan
    Dickerson, Tyler
    Zhao, Qiuhong
    Brammer, Jonathan E.
    Larkin, Karilyn
    Jaglowski, Samantha
    Mims, Alice
    Penza, Sam
    Vasu, Sumithira
    Wall, Sarah A.
    William, Basem M.
    Saad, Ayman
    Roddy, Julianna
    Choe, Hannah
    Puto, Marcin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S156 - S157
12345